NCT02974803 2021-08-20Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain MetastasesCanadian Cancer Trials GroupPhase 2 Terminated6 enrolled 3 charts